Article · 4 May 2026
ArticlePublished 22 Jul 2024
Influence of Metformin in Malignant Development of Liver Cancer Cells through Interferon Regulatory Factor 1
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The pathological mechanism of liver cancer is complex. Interferon regulatory factor-1 can be used as a tumor suppressor, which has an important anti-cancer effect in liver cancer. Metformin has also shown to have therapeutic value in various cancers, but whether it influences the malignant development of liver cancer cells through interferon regulatory factor-1 remains unclear and this study finds out this association. We used cell counting kit-8 to detect the effects of metformin on hepatoma cell lines, HepG2 and Huh-7, interferon regulatory factor-1 levels, cell counting kit-8, and Transwell and flow cytometry to evaluate the role of metformin and interferon regulatory factor-1, Lentivirus interfering vectors on hepatoma cell proliferation, migration and invasion, respectively. The results showed that 10 mM metformin had a significant effect on HepG2 and Huh-7 survival; interferon regulatory factor-1 was significantly under-expressed in HepG2 and HH-7 cells, which could be up-regulated by metformin intervention. Subsequently, metformin intervention was found to validly suppress HepG2 and Huh-7 cells proliferation, migration and invasion, while significantly inducing apoptosis, but the aforementioned anti-tumor effect of metformin was offset by interferon regulatory factor-1 Lentivirus interfering vectors. This indicates that metformin has the ability to inhibit liver cancer cell growth and metastasis, and this effect is related to its regulation of interferon regulatory factor-1.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Peiqi Wan”
- BylineArticles whose byline prints “Chunqiang Dong”
- BylineArticles whose byline prints “Zhihong Liu”
- BylineArticles whose byline prints “Zhang Wen”
- BylineArticles whose byline prints “Huan Liang”
- BylineArticles whose byline prints “Qiuyue Ning”
- BylineArticles whose byline prints “Baiyun Cao”
- BylineArticles whose byline prints “Kun Dong”